Related Experiment Video
Updated: May 27, 2026
07:12
Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021
Potency determination of recombinant IFN-alpha based on phosphorylated STAT1 using flow cytometry
Edson R A de Oliveira1, Bruna M M P Lima, Bárbara A F dos Santos
1Laboratory of Biotechnology and Physiology of Viral Infections, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. edsonrao@yahoo.com.br
Journal of Immunological Methods
|November 26, 2011
Summary
This study introduces a novel flow cytometry method to measure the potency of interferon-alpha (IFN-alpha) biopharmaceuticals by assessing signal transducer and activator of transcription 1 (STAT1) activation, aiding in quality control.
Area of Science:
- Immunology
- Biotechnology
- Virology
Background:
- Interferon (IFN) cytokines are crucial for innate immunity against viral infections.
- Interferon-alpha (IFN-alpha) is a biopharmaceutical primarily used for treating chronic hepatitis C.
- Existing bioassays for IFN potency are varied, necessitating development of practical methods.
Purpose of the Study:
- To present a novel approach for determining the potency of recombinant IFN-alpha preparations.
- To evaluate the utility of signal transducer and activator of transcription 1 (STAT1) activation as a measure of IFN-alpha biological activity.
Main Methods:
- Utilized flow cytometry to detect STAT1 activation.
- Developed a new bioassay based on STAT1 phosphorylation in response to IFN-alpha.
- Assessed the potency of a recombinant IFN-alpha preparation.
Main Results:
- The flow cytometry method effectively measured STAT1 activation induced by IFN-alpha.
- This approach demonstrated utility in assessing the potency of IFN-alpha biopharmaceuticals.
- The method showed promise as a tool for quality control of biological products.
Conclusions:
- A novel flow cytometry-based assay for IFN-alpha potency determination was successfully developed.
- Assessing STAT1 activation provides a reliable method for evaluating IFN-alpha biological activity.
- This technique offers a promising tool for the quality control of IFN-alpha biopharmaceuticals.
